论文部分内容阅读
目的探讨经直肠超声引导下经会阴射频消溶治疗前列腺炎的疗效。方法选取2013年4月至2014年1月,驻马店市中心医院收治的70例前列腺炎患者所有患者均实施经直肠穿刺前列腺注射头孢哌酮-舒巴坦进行消融治疗,分别在治疗1、3、6、12、24个月后随访,并让患者到医院复诊,检测并观察患者治疗后前列腺的体积、最大尿流量、残余尿流量等。结果治疗前后前列腺病理及患者症状、检测指标的变化治疗后穿刺活检病理显示,有45例尿线变细患者,在1周到2周拔出导尿管后,排尿状况较治疗前明显畅通;有25例长期留置导尿管患者,在2周到4周将导管拔除后出现自主排尿。对患者实施注射治疗1个月后,前列腺体积较治疗之间有轻度缩小,在治疗3个月后,患者前列腺体积有明显缩小,在治疗6个月后,患者前列腺体积缩小最为明显,到12个月和24个月后随访观察,患者前列腺体积无增长表现,且与治疗6个月后的体积无明显差异。患者在治疗后尿流率较治疗前明显在增大,在治疗3个月后最为明显,尿量残余也有明显改善,在治疗6个月后改善情况最为明显,对患者随访至24个月后,残余尿路无明显变化。结论对于前列腺炎患者,采用直肠超声引导下注射头孢哌酮-舒巴坦治疗疗效确切,且具有创伤小、安全以及经济的优点,值得临床推广和应用。
Objective To investigate the efficacy of transrectal ultrasound guided percutaneous radiofrequency ablation of prostatitis. Methods From April 2013 to January 2014, 70 patients with prostatitis admitted to Zhumadian Central Hospital were treated with cefoperazone-sulbactam by rectal puncture for rectal ablation. 6,12,24 months after follow-up, and allow patients to the hospital referral, detection and observation of patients after treatment, the volume of the prostate, the maximum flow of urine, residual urine flow and so on. Results Before and after treatment of prostate pathology and changes in patient symptoms and test indicators Post-treatment biopsy pathology showed that there were 45 patients with thinning of the urinary catheter in 1 week to 2 weeks after removal of the catheter, urination was significantly better than before treatment; Twenty-five patients with long-term indwelling catheters developed spontaneous micturition after catheter removal at 2 weeks to 4 weeks. Prostate volume was slightly reduced compared with treatment after 1 month of injection therapy. After 3 months of treatment, the volume of prostate was significantly reduced. After 6 months of treatment, the prostate volume decreased most obviously to After 12 months and 24 months follow-up observation, no increase in the volume of patients with prostate, and the volume of 6 months after treatment no significant difference. Urine flow rate in patients after treatment was significantly increased compared with before treatment, the most obvious after 3 months of treatment, urine output also significantly improved after 6 months of treatment to improve the most obvious, the patient was followed up to 24 months , No significant change in residual urinary tract. Conclusion For patients with prostatitis, the use of cefoperazone-sulbactam injection under the guidance of rectal ultrasound is effective and has the advantages of less trauma, safety and economy, and is worthy of clinical promotion and application.